| Literature DB >> 11165973 |
A S Wierzbicki1, P J Lumb, G Chik, M A Crook.
Abstract
The clinical and biochemical determinants of the fibrinogen response to simvastatin or atorvastatin therapy were assessed in 130 patients with severe polygenic or familial hypercholesterolemia treated in a randomized open-trial format design. Hyperfibrinogenemia was associated with atorvastatin, baseline fibrinogen, and initial concentration and change in concentration of apolipoprotein B or low-density lipoprotein cholesterol.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11165973 DOI： 10.1016/s0002-9149(00)01371-0
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778